Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms

The morbidity and mortality of BCR-ABL-negative myeloproliferative neoplasia (MPN) patients is highly dependent on thrombosis that may be affected by antiphospholipid antibodies (aPLA) and lupus anticoagulant. Our aim was to evaluate the association of the aPLA together with platelet receptor glycop...

Descripción completa

Detalles Bibliográficos
Autores principales: Dambrauskienė, Rūta, Gerbutavičius, Rolandas, Rudžianskienė, Milda, Paukštaitienė, Renata, Vitkauskienė, Astra, Skrodenienė, Erika, Remeikienė, Diana, Zaborienė, Inga, Juozaitytė, Elona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: De Gruyter 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922056/
https://www.ncbi.nlm.nih.gov/pubmed/36816798
http://dx.doi.org/10.1515/biol-2022-0545

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922056/
https://www.ncbi.nlm.nih.gov/pubmed/36816798
http://dx.doi.org/10.1515/biol-2022-0545

Ejemplares similares